NICE links with EMIG
The National Institute for Health and Care Excellence and the Ethical Medicines Industry Group (EMIG) are working together to increase understanding of the services the Institute offers the life sciences industry.
Read More
Tag: EMIG
Pharma agrees to 2% cap on branded meds growth
The Association of the British Pharmaceutical Industry has agreed the terms of the 2019 Pharmaceutical Price Regulation Scheme (PPRS) with the government, which is expected to come into effect from January.
Read More
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
